Anti-inflammatory Nutraceuticals and Chronic Diseases, 1st ed. 2016 Advances in Experimental Medicine and Biology Series, Vol. 928

This comprehensive volume focuses on anti-inflammatory nutraceuticals and their role in various chronic diseases. Food and Drug Administration (FDA) approved drugs such as steroids, non-steroidal anti-inflammatory drugs (NSAIDS), statins and metformin have been shown to modulate inflammatory pathways, but their long-term intake has been associated with numerous side effects. This means that there is enormous potential for dietary agents that can modulate inflammatory pathways in humans. Leading experts describe the latest research on the role of anti-inflammatory nutraceuticals in preventing and treating chronic diseases.

Dr. Subash Gupta is currently an Assistant professor at Department of Biochemistry, Institute of Science, Banaras Hindu University, India. 

Dr. Sahdeo Prasad is currently at the Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, USA.

Dr. Bharat Aggarwal is currently a Founding Director, Inflammation Research Institute, San Diego, California, USA. He was a Ransom Horne, Jr. Distinguished Professor of Experimental Therapeutics, Cancer Medicine and Immunology, The University of Texas MD Anderson Cancer Center, USA.